National Storage Mechanism | Additional information

RNS Number : 1800S

Willis Towers Watson PLC

06 July 2020

Ap9

APPENDIX 3

DISCLOSURE FORMS

FORM 8.1(a)&(b)(i)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

1. KEY INFORMATION


Name of person dealing (Note 1)	Jaymin B. Patel
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	Ordinary Shares of $0.000304635 each
Date of dealing	10 June 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)


	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	Ordinary Shares: 4,697 (0.0036%)
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	RSU: 803 (0.0062%)
Total	5,500 (0.0042%)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)


Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	N/A
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	N/A
Total	N/A

Ap10

3. DEALINGS (Note 4)

(a) Purchases and sales


Purchase/sale	Number of relevant securities	Price per unit (Note 5)

(b) Derivatives transactions (other than options transactions)


Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(i) Writing, selling, purchasing or varying


Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
RSU	Grant	803	N/A	N/A	N/A	N/A

(ii) Exercising


Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)


Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap11

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and

any other person relating to the voting rights of any relevant securities under any option referred to

on this form or relating to the voting rights or future acquisition or disposal of any relevant

securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO


Date of disclosure	6 July 2020
Contact name	Nicole Napolitano
Telephone number	+1 (212) 915-8098
Name of offeree/offeror with which acting in concert	Willis Towers Watson plc
Specify category and nature of acting in concert status	Director

Ap9

APPENDIX 3

DISCLOSURE FORMS

FORM 8.1(a)&(b)(i)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

5. KEY INFORMATION


Name of person dealing (Note 1)	Wendy E. Lane
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	Ordinary Shares of $0.000304635 each
Date of dealing	10 June 2020

6. INTERESTS AND SHORT POSITIONS


	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	Ordinary Shares: 6,916 (0.0053%)
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	RSU: 803 (0.0006%)
Total	7,719 (0.0059%)

(d) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)


Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	N/A
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	N/A
Total	N/A

Ap10

7. DEALINGS (Note 4)

(e) Purchases and sales


Purchase/sale	Number of relevant securities	Price per unit (Note 5)

(f) Derivatives transactions (other than options transactions)


Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(g) Options transactions in respect of existing relevant securities

(iii) Writing, selling, purchasing or varying


Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
RSU	Grant	803	N/A	N/A	N/A	N/A

(iv) Exercising


Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(h) Other dealings (including transactions in respect of new securities) (Note 4)


Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap11

8. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any

other person relating to the voting rights of any relevant securities under any option referred to on this

form or relating to the voting rights or future acquisition or disposal of any relevant

securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO


Date of disclosure	6 July 2020
Contact name	Nicole Napolitano
Telephone number	+1 (212) 915-8098
Name of offeree/offeror with which acting in concert	Willis Towers Watson plc
Specify category and nature of acting in concert status	Director

Ap9

APPENDIX 3

DISCLOSURE FORMS

FORM 8.1(a)&(b)(i)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

9. KEY INFORMATION


Name of person dealing (Note 1)	Anna C. Catalano
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	Ordinary Shares of $0.000304635 each
Date of dealing	10 June 2020

10. INTERESTS AND SHORT POSITIONS

(e) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)


	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	Ordinary Shares: 5,244(0.0040%)
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	RSU: 803 (0.00062%)
Total	6,047(0.0046%)

(f) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)


Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	N/A
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	N/A
Total	N/A

Ap10

11. DEALINGS (Note 4)

(i) Purchases and sales


Purchase/sale	Number of relevant securities	Price per unit (Note 5)

(j) Derivatives transactions (other than options transactions)


Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(k) Options transactions in respect of existing relevant securities

(v) Writing, selling, purchasing or varying


Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
RSU	Grant	803	N/A	N/A	N/A	N/A

(vi) Exercising


Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(l) Other dealings (including transactions in respect of new securities) (Note 4)


Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap11

12. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any

other person relating to the voting rights of any relevant securities under any option referred to on this

form or relating to the voting rights or future acquisition or disposal of any

relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO


Date of disclosure	6 July 2020
Contact name	Nicole Napolitano
Telephone number	+1 (212) 915-8098
Name of offeree/offeror with which acting in concert	Willis Towers Watson plc
Specify category and nature of acting in concert status	Director

Ap9

APPENDIX 3

DISCLOSURE FORMS

FORM 8.1(a)&(b)(i)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

13. KEY INFORMATION


Name of person dealing (Note 1)	Linda D. Rabbitt
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	Ordinary Shares of $0.000304635 each
Date of dealing	10 June 2020

14. INTERESTS AND SHORT POSITIONS

(g) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)


	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	Ordinary Shares: 12,996(0.010%)
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	RSU:803 (0.00062%)
Total	13,799(0.0107%)

(h) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)


Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	N/A
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	N/A
Total	N/A

Ap10

15. DEALINGS (Note 4)

(m) Purchases and sales


Purchase/sale	Number of relevant securities	Price per unit (Note 5)

(n) Derivatives transactions (other than options transactions)


Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(o) Options transactions in respect of existing relevant securities

(vii) Writing, selling, purchasing or varying


Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
RSU	Grant	803	N/A	N/A	N/A	N/A

(viii) Exercising


Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(p) Other dealings (including transactions in respect of new securities) (Note 4)


Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap11

16. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any

other person relating to the voting rights of any relevant securities under any option referred to on this

form or relating to the voting rights or future acquisition or disposal of any relevant

securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO


Date of disclosure	6 July 2020
Contact name	Nicole Napolitano
Telephone number	+1 (212) 915-8098
Name of offeree/offeror with which acting in concert	Willis Towers Watson plc
Specify category and nature of acting in concert status	Director

Ap9

APPENDIX 3

DISCLOSURE FORMS

FORM 8.1(a)&(b)(i)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

17. KEY INFORMATION


Name of person dealing (Note 1)	Wilhelm Zeller
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	Ordinary Shares of $0.000304635 each
Date of dealing	10 June 2020

18. INTERESTS AND SHORT POSITIONS

(i) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)


	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	Ordinary Shares: 7,726 (0.006%)
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	RSU: 1,431 (0.001%)
Total	9,157 (0.007%)

(j) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)


Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	N/A
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	N/A
Total	N/A

Ap10

19. DEALINGS (Note 4)

(q) Purchases and sales


Purchase/sale	Number of relevant securities	Price per unit (Note 5)

(r) Derivatives transactions (other than options transactions)


Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(s) Options transactions in respect of existing relevant securities

(ix) Writing, selling, purchasing or varying


Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
RSU	Grant	1,431	N/A	N/A	N/A	N/A

(x) Exercising


Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(t) Other dealings (including transactions in respect of new securities) (Note 4)


Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap11

20. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any

other person relating to the voting rights of any relevant securities under any option referred to on

this form or relating to the voting rights or future acquisition or disposal of any relevant

securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO


Date of disclosure	6 July 2020
Contact name	Nicole Napolitano
Telephone number	+1 (212) 915-8098
Name of offeree/offeror with which acting in concert	Willis Towers Watson plc
Specify category and nature of acting in concert status	Director

Ap9

APPENDIX 3

DISCLOSURE FORMS

FORM 8.1(a)&(b)(i)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

21. KEY INFORMATION


Name of person dealing (Note 1)	Brendan R. O'Neill
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	Ordinary Shares of $0.000304635 each
Date of dealing	10 June 2020

22. INTERESTS AND SHORT POSITIONS

(k) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)


	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	Ordinary Shares: 12,309 (0.0095%)
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	RSU: 803 (0.00062%)
Total	13,112 (0.0101%)

(l) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)


Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	N/A
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	N/A
Total	N/A

Ap10

23. DEALINGS (Note 4)

(u) Purchases and sales


Purchase/sale	Number of relevant securities	Price per unit (Note 5)

(v) Derivatives transactions (other than options transactions)


Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(w) Options transactions in respect of existing relevant securities

(xi) Writing, selling, purchasing or varying


Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
RSU	Grant	803	N/A	N/A	N/A	N/A

(xii) Exercising


Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(x) Other dealings (including transactions in respect of new securities) (Note 4)


Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap11

24. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and

any other person relating to the voting rights of any relevant securities under any option referred

to on this form or relating to the voting rights or future acquisition or disposal of any

relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO


Date of disclosure	6 July 2020
Contact name	Nicole Napolitano
Telephone number	+1 (212) 915-8098
Name of offeree/offeror with which acting in concert	Willis Towers Watson plc
Specify category and nature of acting in concert status	Director

Ap9

APPENDIX 3 DISCLOSURE FORMS

FORM 8.1(a)&(b)(i)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

25. KEY INFORMATION


Name of person dealing (Note 1)	Victor Ganzi
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	Ordinary Shares of $0.000304635 each
Date of dealing	10 June 2020

26. INTERESTS AND SHORT POSITIONS

(m) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)


	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	Ordinary Shares: 19,251 (0.0149%)
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	RSU: 2,184 (0.0016%)
Total	21,435 (0.0166%)

(n) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)


Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap10

27. DEALINGS (Note 4)

(y) Purchases and sales


Purchase/sale	Number of relevant securities	Price per unit (Note 5)

(z) Derivatives transactions (other than options transactions)


Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(aa) Options transactions in respect of existing relevant securities

(xiii) Writing, selling, purchasing or varying


Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
RSU	Grant	2,184	N/A	N/A	N/A	N/A

(xiv) Exercising


Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(bb) Other dealings (including transactions in respect of new securities) (Note 4)


Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap11

28. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and

any other person relating to the voting rights of any relevant securities under any option referred

to on this form or relating to the voting rights or future acquisition or disposal of any

relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO


Date of disclosure	6 July 2020
Contact name	Nicole Napolitano
Telephone number	+1 (212) 915-8098
Name of offeree/offeror with which acting in concert	Willis Towers Watson plc
Specify category and nature of acting in concert status	Director

Ap9

APPENDIX 3

DISCLOSURE FORMS

FORM 8.1(a)&(b)(i)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

29. KEY INFORMATION


Name of person dealing (Note 1)	Paul Thomas
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	Ordinary Shares of $0.000304635 each
Date of dealing	10 June 2020

30. INTERESTS AND SHORT POSITIONS

(o) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)


	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	Ordinary Shares: 10,222 (0.0079%)
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	RSU: 803 (0.00062%)
Total	11,025 (0.0085%)

(p) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)


Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	N/A
(2) Derivatives (other than options)	N/A
(3) Options and agreements to purchase/sell	N/A
Total	N/A

Ap10

31. DEALINGS (Note 4)

(cc) Purchases and sales


Purchase/sale	Number of relevant securities	Price per unit (Note 5)

(dd) Derivatives transactions (other than options transactions)


Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(ee) Options transactions in respect of existing relevant securities

(xv) Writing, selling, purchasing or varying


Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
RSU	Grant	803	N/A	N/A	N/A	N/A

(xvi) Exercising


Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(ff) Other dealings (including transactions in respect of new securities) (Note 4)


Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap11

32. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and

any other person relating to the voting rights of any relevant securities under any option referred to

on this form or relating to the voting rights or future acquisition or disposal of any relevant

securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO


Date of disclosure	6 July 2020
Contact name	Nicole Napolitano
Telephone number	+1 (212) 915-8098
Name of offeree/offeror with which acting in concert	Willis Towers Watson plc
Specify category and nature of acting in concert status	Director

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ISEUPUACMUPUGQQ

AI assistant

WILLIS TOWERS WATSON PLC — Director's Dealing 2020

30135_mrq_2020-07-06_e55ff29f-7b7e-4652-9ae7-9787d07f4164.html

Ap9

APPENDIX 3

Ap10

Ap11

4. OTHER INFORMATION

Ap9

APPENDIX 3

Ap10

Ap11

8. OTHER INFORMATION

Ap9

APPENDIX 3

Ap10

Ap11

12. OTHER INFORMATION

Ap9

APPENDIX 3

Ap10

Ap11

16. OTHER INFORMATION

Ap9

APPENDIX 3

Ap10

Ap11

20. OTHER INFORMATION

Ap9

APPENDIX 3

Ap10

Ap11

24. OTHER INFORMATION

Ap9

APPENDIX 3 DISCLOSURE FORMS

Ap10

Ap11

28. OTHER INFORMATION

Ap9

APPENDIX 3

Ap10

Ap11

32. OTHER INFORMATION

More from WILLIS TOWERS WATSON PLC

WILLIS TOWERS WATSON PLC Director's Dealing 2020